Clinical Trial
-
Spine
Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial
LOUISVILLE, Colo., Sept. 25, 2024 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopedic medical device developer focused on artificial cervical disc replacement,…
Read More » -
Spine
Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain
NEW YORK, September 24, 2024 –(BUSINESS WIRE)– Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for…
Read More » -
Sports Medicine
Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ — Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that…
Read More » -
Spine
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With…
Read More » -
Spine
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Surgeons Will Determine Their Surgical Treatment Plan Before Nociscan and Report on How Often the Surgical Plan Changes After Receiving…
Read More » -
Spine
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix® Spinal System
THE HAGUE, Netherlands, June 11, 2024 /PRNewswire/ — Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants…
Read More » -
Recon
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
Randomized Clinical Trial to Explore the Efficacy of Concentrated Bone Marrow Aspirate as an Addition to ACL Revision Surgery NEW…
Read More » -
Biologics
Bone Biologics Reports Progress With NB1 Clinical Program
BURLINGTON, Mass., March 1, 2024–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress…
Read More » -
Financial
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when…
Read More » -
Biologics
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation — —…
Read More » -
Spine
3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023
3Spine MOTUS Lumbar Total Joint Replacement Procedure CHATTANOOGA, Tenn., Jan. 10, 2024 /PRNewswire/ — 3Spine, Inc., a medical device company developing a…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Spine
Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures THE HAGUE, Netherlands, Oct. 3, 2023 /PRNewswire/ — Amber Implants, an innovative medical…
Read More » -
Biologics
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million
FREDERICK, Md., Sept. 26, 2023 /PRNewswire/ — Today, Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded…
Read More » -
Biologics
BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
–Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— –15 Clinical Sites Identified, 12…
Read More »